tirzepatide stings Tirzepatide-Induced Injection Site Reaction Understanding Tirzepatide Side Effects, Risks

Zepbound (tirzepatide) is a dual GIP/GLP-1 receptor agonist approved by the FDA for chronic weight management in adults with obesity or overweight with weight-related conditions

Further information for consumers on the dangers of purchasing medicines online is available here

Date: November 16, 2025 Source: Cochrane Summary: GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility

A sizeable fraction of patients receiving semaglutide also achieved the combined endpoint of MASH resolution plus 1-stage fibrosis improvement, with an absolute benefit of approximately 15-17 percentage points over placebo [7]